Alexis Denis

USPTO Granted Patents = 9 (Patent Applications = 2)

CIPO Patents = 3 (Patent Applications = 5)

EPO Patents = 5 (Patent Applications = 3)

Average Co-Inventor Count = 3.5

ph-index = 1

Forward Citations = 6(Granted Patents)

Location History:

Les Ulis, FR (2017 - 2020)
Villebon-sur-Yvette, FR (2019 - 2020)

Company Filing History:

8 out of 230

Glaxosmithkline Intellectual Property Development Limited

patents

1 out of 168

The University of Edinburgh

patents

Years Active: 2017-2020

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10611756 - Method of treating pancreatitis using 1,4-benzoxazine derivatives (2020-04-07),

2. 10597385 - Prodrug of 1,1'-(1,6-dioxo-1,6-hexanediyl)bis-D-proline (2020-03-24),

3. 10328052 - D-proline derivatives as SAP depleting agent (2019-06-25),

4. 10273232 - 3-(6-alkoxy-5-chlorobenzo[D]isoxazol-3-YL)propanoic acid useful as kynurenine monooxygenase inhibitors (2019-04-30),

5. 10246447 - 3-(6-chloro-3-oxo-3,4-dihydro-(2H)-1,4-benzoxazin-4-yl) propanoic acid derivatives and their use as KMO inhibitors (2019-04-02),

6. 9932328 - 3-(6-alkoxy-5-chlorobenzo[d]isoxazol-3-yl)propanoic acid useful as kynurenine monooxygenase inhibitors (2018-04-03),

7. 9873686 - Prodrug of 1,1'-(1,6-dioxo -1,6-hexanediyl)bis-D-proline (2018-01-23),

8. 9737505 - Prodrug of 1,1'-(1,6-dioxo-1,6-hexanediyl)bis-D-proline (2017-08-22),

9. 9701668 - Prodrug of 1,1'-(1,6-dioxo-1,6-hexanediyl)bis-D-proline (2017-07-11),

Title: Innovations and Contributions of Inventor Alexis Denis

Introduction

Alexis Denis is a notable inventor based in Les Ulis, France. He has made significant contributions to the field of pharmaceuticals, holding a total of 9 patents. His work primarily focuses on innovative methods for treating various medical conditions.

Latest Patents

One of his latest patents is a method of treating pancreatitis using 1,4-benzoxazine derivatives. This invention relates to methods and uses for treating pancreatitis, kidney diseases, and other disorders mediated by KMO inhibitors. It involves administering 6-chlorobenzoxazine compounds of a specific formula, along with pharmaceutically acceptable salts and corresponding pharmaceutical compositions. Another significant patent is for a prodrug of 1,1'-(1,6-dioxo-1,6-hexanediyl)bis-D-proline. This invention pertains to a compound that can be used for treating diseases where the depletion of serum amyloid P component (SAP) would be beneficial, including conditions such as amyloidosis, Alzheimer's disease, type 2 diabetes mellitus, and osteoarthritis.

Career Highlights

Throughout his career, Alexis Denis has worked with prominent organizations, including GlaxoSmithKline Intellectual Property Development Limited and the University of Edinburgh. His experience in these institutions has allowed him to develop and refine his innovative ideas in the pharmaceutical sector.

Collaborations

Some of his notable coworkers include Olivier Mirguet and Jérôme Toum. Their collaborative efforts have contributed to the advancement of research and development in their respective fields.

Conclusion

Alexis Denis is a distinguished inventor whose work has significantly impacted the pharmaceutical industry. His innovative patents and collaborations highlight his commitment to advancing medical treatments.

This text is generated by artificial intelligence and may not be accurate.